TrialMedicine2018

Early tumor shrinkage served as a prognostic factor for patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy.

Min Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.